DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mucoactive agent
Mucoactive agent
Bronchiectasis (Non-Cystic Fibrosis), Acute Exacerbation: Antimicrobial Prescribing Evidence Review
(12) United States Patent (10) Patent No.: US 9,314.465 B2 Brew Et Al
Pharmacotherapy of Impaired Mucociliary Clearance in Non-CF Pediatric Lung Disease
Secretion Properties, Clearance, and Therapy in Airway Disease Bruce K Rubin
WO 2012/050945 Al
Mucoactive Agents for Airway Mucus Hypersecretory Diseases
Mucoactive Agent Use in Adult UK Critical Care Units
Handbook of Pharmaceutical Excipients
Anti-Inflammatory Activity and Mucolytic Effect of Ambroxol in Patients with Stable Chronic Bronchitis ─ a Preliminary Report
Download Book
Delivery of High Solubility Polyols by Vibrating Mesh Nebulizer to Enhance Mucociliary Clearance
In the Management of Chronic Obstructive Pulmonary Disease
Effects of Bromelain and N-Acetylcysteine on Mucin
Public Assessment Report Scientific Discussion Rivendra Ambroxol
Mucoactive Effect Evaluation and Acute Toxicity Study Of
Annex Iii Labelling and Package Leaflet
HERBAL ANTITUSSIVES and EXPECTORANTS – a REVIEW Review Article
Rubin Mucoactive CIPP 8
Top View
Effect of Herbal Syrup Linkus on Acute and Gross Toxicity And
Annual Report on Form 20-F 2018
Mucolytics, Expectorants, and Mucokinetic Medications
A Modern Approach to Cough Management
Bronchitolformanageme
Changes in Terminology and Management of Over-The-Counter Cough Therapy – Time for a Fresh Perspective?
Anatte Margalit, B.Sc
The Korean Cough Guideline: Recommendation and Summary Statement
(10) Patent No.: US 8992983 B2
An Overview of Efficacy and Safety of Ambroxol for the Treatment of Acute and Chronic Respiratory Diseases with a Special Regard to Children
Mucoactive Agents for Acute Respiratory Failure in the Critically
Antitussive Drugs—Past, Present, and Future
Ambroxol in the 21St Century: Pharmacological and Clinical Update
Introducción
Use of Dornase Alfa in Cystic Fibrosis: an Audit of Italian Specialists
Guideline Bronchiectasis (Non-Cystic Fibrosis), Acute Exacerbation: Antimicrobial Prescribing Guideline Draft for Consultation, July 2018
Acetylcysteine for Patients Requiring Mucous Secretion Clearance: a Review of Clinical Effectiveness and Safety
(12) Patent Application Publication (10) Pub. No.: US 2010/0166673 A1 Surber Et Al